{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Multi+Center&page=89", "query": { "condition": "Multi Center", "page": 89 }, "page_size": 10 }, "pagination": { "page": 89, "page_size": 10, "total_count": 6602, "total_pages": 661, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Multi+Center&page=90&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Multi+Center&page=88&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-10T18:24:35.639Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01308463", "title": "Discovery Elbow Long-Term Survivorship", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Survivorship", "Pain" ], "interventions": [ { "name": "Discovery elbow minimally constrained", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Zimmer Biomet", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 29, "start_date": "2011-01", "completion_date": "2016-09", "has_results": true, "last_update_posted_date": "2017-05-01", "last_synced_at": "2026-11-10T18:24:35.639Z", "location_count": 4, "location_summary": "Tampa, Florida • Indianapolis, Indiana • Boston, Massachusetts + 1 more", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01308463" }, { "nct_id": "NCT02484690", "title": "A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Choroidal Neovascularization" ], "interventions": [ { "name": "Faricimab", "type": "DRUG" }, { "name": "Ranibizumab", "type": "DRUG" }, { "name": "Sham Procedure", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 273, "start_date": "2015-08-11", "completion_date": "2017-09-26", "has_results": true, "last_update_posted_date": "2020-11-12", "last_synced_at": "2026-11-10T18:24:35.639Z", "location_count": 52, "location_summary": "Phoenix, Arizona • Bakersfield, California • Beverly Hills, California + 46 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Encino", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02484690" }, { "nct_id": "NCT01499420", "title": "A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Stable Atherothrombotic Disease" ], "interventions": [ { "name": "CSL112 (reconstituted high density lipoprotein)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "CSL Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 45, "start_date": "2012-02", "completion_date": "2013-03", "has_results": false, "last_update_posted_date": "2014-02-06", "last_synced_at": "2026-11-10T18:24:35.639Z", "location_count": 11, "location_summary": "Chula Vista, California • Jacksonville, Florida • Miami, Florida + 8 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Madisonville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT01499420" }, { "nct_id": "NCT00918424", "title": "Long Term Study of the Safety of OXC XR as in Pediatric Epilepsy Subjects", "overall_status": "APPROVED_FOR_MARKETING", "study_type": "EXPANDED_ACCESS", "phases": [], "conditions": [ "Epilepsy" ], "interventions": [ { "name": "Oxcarbazepine Extended Release", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Supernus Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "4 Years to 17 Years" }, "enrollment_count": null, "start_date": "2009-06", "completion_date": null, "has_results": false, "last_update_posted_date": "2017-05-09", "last_synced_at": "2026-11-10T18:24:35.639Z", "location_count": 6, "location_summary": "Loxahatchee Groves, Florida • Palm Beach, Florida • Rockville, Maryland + 3 more", "locations": [ { "city": "Loxahatchee Groves", "state": "Florida" }, { "city": "Palm Beach", "state": "Florida" }, { "city": "Rockville", "state": "Maryland" }, { "city": "Rochester", "state": "New York" }, { "city": "Kingsport", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00918424" }, { "nct_id": "NCT00555880", "title": "Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypotension, Orthostatic" ], "interventions": [ { "name": "Midodrine hydrochloride", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 24, "start_date": "2004-09-08", "completion_date": "2005-03-21", "has_results": true, "last_update_posted_date": "2021-06-14", "last_synced_at": "2026-11-10T18:24:35.639Z", "location_count": 11, "location_summary": "Fort Wayne, Indiana • Boston, Massachusetts • Ann Arbor, Michigan + 8 more", "locations": [ { "city": "Fort Wayne", "state": "Indiana" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00555880" }, { "nct_id": "NCT05908448", "title": "The True Vie I3 Continuous Glucose Monitoring System in Pediatric Patients With Type 1 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "T1DM - Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "13 CGM (continuous glucose monitor)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Sinocare", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 134, "start_date": "2024-02-07", "completion_date": "2024-11-13", "has_results": false, "last_update_posted_date": "2024-12-03", "last_synced_at": "2026-11-10T18:24:35.639Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05908448" }, { "nct_id": "NCT00025415", "title": "Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Accelerated Phase Chronic Myelogenous Leukemia", "Acute Undifferentiated Leukemia", "AIDS-related Peripheral/Systemic Lymphoma", "AIDS-related Primary CNS Lymphoma", "Anaplastic Large Cell Lymphoma", "Angioimmunoblastic T-cell Lymphoma", "Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative", "Blastic Phase Chronic Myelogenous Leukemia", "Childhood Myelodysplastic Syndromes", "Chronic Eosinophilic Leukemia", "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Chronic Myelomonocytic Leukemia", "Chronic Neutrophilic Leukemia", "Chronic Phase Chronic Myelogenous Leukemia", "de Novo Myelodysplastic Syndromes", "Essential Thrombocythemia", "Extramedullary Plasmacytoma", "Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue", "Gastrointestinal Stromal Tumor", "Intraocular Lymphoma", "Isolated Plasmacytoma of Bone", "Meningeal Chronic Myelogenous Leukemia", "Monoclonal Gammopathy of Undetermined Significance", "Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable", "Nodal Marginal Zone B-cell Lymphoma", "Polycythemia Vera", "Previously Treated Myelodysplastic Syndromes", "Primary Central Nervous System Non-Hodgkin Lymphoma", "Primary Myelofibrosis", "Primary Systemic Amyloidosis", "Progressive Hairy Cell Leukemia, Initial Treatment", "Prolymphocytic Leukemia", "Recurrent Adult Acute Lymphoblastic Leukemia", "Recurrent Adult Acute Myeloid Leukemia", "Recurrent Adult Burkitt Lymphoma", "Recurrent Adult Diffuse Large Cell Lymphoma", "Recurrent Adult Diffuse Mixed Cell Lymphoma", "Recurrent Adult Diffuse Small Cleaved Cell Lymphoma", "Recurrent Adult Hodgkin Lymphoma", "Recurrent Adult Immunoblastic Large Cell Lymphoma", "Recurrent Adult Lymphoblastic Lymphoma", "Recurrent Adult T-cell Leukemia/Lymphoma", "Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma", "Recurrent Grade 1 Follicular Lymphoma", "Recurrent Grade 2 Follicular Lymphoma", "Recurrent Grade 3 Follicular Lymphoma", "Recurrent Mantle Cell Lymphoma", "Recurrent Marginal Zone Lymphoma", "Recurrent Mycosis Fungoides/Sezary Syndrome", "Recurrent Small Lymphocytic Lymphoma", "Refractory Chronic Lymphocytic Leukemia", "Refractory Hairy Cell Leukemia", "Refractory Multiple Myeloma", "Relapsing Chronic Myelogenous Leukemia", "Secondary Acute Myeloid Leukemia", "Secondary Myelodysplastic Syndromes", "Small Intestine Lymphoma", "Splenic Marginal Zone Lymphoma", "Stage IV Adult Burkitt Lymphoma", "Stage IV Adult Diffuse Large Cell Lymphoma", "Stage IV Adult Diffuse Mixed Cell Lymphoma", "Stage IV Adult Diffuse Small Cleaved Cell Lymphoma", "Stage IV Adult Hodgkin Lymphoma", "Stage IV Adult Immunoblastic Large Cell Lymphoma", "Stage IV Adult Lymphoblastic Lymphoma", "Stage IV Adult T-cell Leukemia/Lymphoma", "Stage IV Chronic Lymphocytic Leukemia", "Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage IV Grade 1 Follicular Lymphoma", "Stage IV Grade 2 Follicular Lymphoma", "Stage IV Grade 3 Follicular Lymphoma", "Stage IV Mantle Cell Lymphoma", "Stage IV Marginal Zone Lymphoma", "Stage IV Mycosis Fungoides/Sezary Syndrome", "Stage IV Small Lymphocytic Lymphoma", "T-cell Large Granular Lymphocyte Leukemia", "Unspecified Adult Solid Tumor, Protocol Specific", "Untreated Adult Acute Lymphoblastic Leukemia", "Untreated Adult Acute Myeloid Leukemia", "Untreated Hairy Cell Leukemia", "Waldenström Macroglobulinemia" ], "interventions": [ { "name": "imatinib mesylate", "type": "DRUG" }, { "name": "pharmacological study", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": null, "sex": "ALL", "summary": "15 Years and older" }, "enrollment_count": 60, "start_date": "2001-08", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-02-07", "last_synced_at": "2026-11-10T18:24:35.639Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00025415" }, { "nct_id": "NCT00824460", "title": "Study of Phosphate Levels in Patients With Chronic Kidney Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Kidney Disease" ], "interventions": [ { "name": "1.25 g PA21 (250 mg iron)", "type": "DRUG" }, { "name": "5.0 g PA21 (1,000 mg iron)", "type": "DRUG" }, { "name": "7.5 g PA21 (1,500 mg iron)", "type": "DRUG" }, { "name": "10.0 g PA21 (2,000 mg iron)", "type": "DRUG" }, { "name": "12.5 g PA21 (2,500 mg iron)", "type": "DRUG" }, { "name": "Sevelamer hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vifor Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 154, "start_date": "2008-12", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2014-04-01", "last_synced_at": "2026-11-10T18:24:35.639Z", "location_count": 9, "location_summary": "Arvada, Colorado • Denver, Colorado • Pembroke Pines, Florida + 6 more", "locations": [ { "city": "Arvada", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" }, { "city": "Pembroke Pines", "state": "Florida" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Fresh Meadows", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00824460" }, { "nct_id": "NCT00481520", "title": "Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "SAM-531", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "50 Years to 90 Years" }, "enrollment_count": 72, "start_date": "2007-06", "completion_date": "2008-01", "has_results": false, "last_update_posted_date": "2009-09-30", "last_synced_at": "2026-11-10T18:24:35.639Z", "location_count": 7, "location_summary": "Delray Beach, Florida • Hallandale, Florida • St. Petersburg, Florida + 4 more", "locations": [ { "city": "Delray Beach", "state": "Florida" }, { "city": "Hallandale", "state": "Florida" }, { "city": "St. Petersburg", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Long Branch", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00481520" }, { "nct_id": "NCT05026710", "title": "Better Lithotripsy and Ureteroscopy Evaluation of Stenting (BLUES)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Renal Stone", "Ureteral Stone" ], "interventions": [ { "name": "Silicone (Coloplast Imajin Hydro) ureteral stent", "type": "DEVICE" }, { "name": "Non-silicone (Polyurethane/Percuflex) ureteral stent (any manufacturer)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 224, "start_date": "2021-12-02", "completion_date": "2024-08-21", "has_results": true, "last_update_posted_date": "2025-10-28", "last_synced_at": "2026-11-10T18:24:35.639Z", "location_count": 10, "location_summary": "Ann Arbor, Michigan • Brighton, Michigan • Chelsea, Michigan + 7 more", "locations": [ { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Brighton", "state": "Michigan" }, { "city": "Chelsea", "state": "Michigan" }, { "city": "Clinton Township", "state": "Michigan" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05026710" } ] }